Back to Top Skip to main content

Department of Defense continues commitment to Global Health Security Agenda

Dr. Karen Guice, acting assistant secretary of Defense for Health Affairs, addressed attendees on the second day of the 2016 Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (TBI) Summit Sept. 14, 2016. Dr. Karen Guice, acting assistant secretary of Defense for Health Affairs

Recommended Content:

Health Readiness | Global Health Engagement | Building Partner Capacity and Interoperability | Global Health Security Agenda | Armed Forces Health Surveillance Branch

Infectious disease is a threat that never sleeps. In the past few years, illnesses like Zika virus, Ebola, Middle East respiratory syndrome, and countless others posed serious challenges for public health officials in many countries. As the world grows ever more connected, these threats continue to multiply and spread across the globe with increasing speed and unpredictability. The need for a decisive, coordinated global response to meet these challenges head on is clear.

That need is the focus of discussion at the high level ministerial meeting of the Global Health Security Agenda (GSHA) being held Oct. 12-14, 2016 in the Netherlands. Acting Assistant Secretary of Defense for Health Affairs Dr. Karen Guice is representing the Department of Defense (DoD) and the Military Health System alongside leaders from several other U.S. government agencies. The U.S. delegation joins dignitaries from more than 50 nations, international organizations and non-government partners in gathering to discuss recent progress on the initiative and look ahead to the future.

U.S. Government Global Health Security Agenda PartnersU.S. Government Global Health Security Agenda Partners

 

GHSA is a growing partnership devoted to increasing countries’ capacities to prevent, detect and respond to endemic and emerging infectious disease threats whether naturally occurring, accidental or deliberate. The partnership seeks to achieve its goals through the integration of human and veterinary medicine and environmental science, and the implementation of the World Health Organization’s International Health Regulations (IHR). The agenda is a Presidential priority, and DoD joins a whole of government commitment by the United States to partner with 31 countries to advance GHSA objectives during the next five years.

This 2016 meeting encourages all partners to accelerate their progress by identifying near-term actions, including increasing collaboration and partnership across the public health community, non-government organizations and the private sector. DoD supports the U.S. commitment to GHSA through its existing initiatives aligned with the targets of the GHSA engagement activities.

GHSA also addresses issues of biodefense, biosafety and biosecurity and emergency response operations, and force health protection through biosurveillance, diagnostics and medical countermeasures at home and abroad. GHSA oversight and coordination efforts for the Military Health System are led by the Defense Health Agency’s Armed Forces Health Surveillance Branch (AFHSB) which supports force health protection activities to meet national security objectives.

AFHSB plays a critical role in force health protection and is the central epidemiologic and global health surveillance resource for the U.S. military. The Global Emerging Infections Surveillance Response System (GEIS) works with 23 DoD overseas and U.S.-based laboratories operating a regional network to coordinate a global program of militarily relevant infectious disease surveillance. GEIS surveillance network efforts reach more than 70 countries with engagement organized around emerging infectious disease program areas including antimicrobial resistant, gastrointestinal, febrile and vector-borne, respiratory and sexually transmitted infections.

The mission and objectives of the Defense Threat Reduction Agency’s Cooperative Biological Engagement Program (CBEP) are also closely aligned with the GHSA and many of its activities contribute to the U.S. commitment in partner countries. In 2015 CBEP partnered with the U.S. Army Medical Research Institute for Infectious Diseases to train more than 200 participants from countries throughout East Africa in laboratory training to strengthen their countries’ health systems. The effort focused on teaching participants to distinguish a particular disease or condition from others presenting similar clinical features (known as differential diagnosis) such as the vector-borne infections Chikungunya and Dengue.

"Addressing the risk from infectious diseases, whether naturally occurring or intentionally spread, is essential to protecting the American people, protecting our allies and interests and preserving stability around the globe,” said Deputy Secretary of Defense Robert O. Work. “Department of Defense support to the Global Health Security Agenda includes working to build capacity of international militaries and civilian partners, research into combating bio-threats and support to crisis response efforts that no other nation can match, as demonstrated by our close cooperation with the Centers for Disease Control and Prevention and other federal and international partners in combating Ebola. We're committed to continued support of these efforts as the Global Health Security Agenda moves forward."

You also may be interested in...

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

Armed Forces Reportable Medical Events Guidelines and Case Definitions Memo

Policy

The Armed Forces Reportable Medical Events Guidelines and Case Definitions (RME Guidelines) standardize reporting and tracking of disease and other conditions of public health and military importance. Timely reporting permits earlier recognition of public health events and interventions to protect the health of the force.

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

DoD Laboratories Participating in CDC Laboratory Response Network 03-213

Policy

Department of Defense (DoD) laboratories participating in the Centers for Disease Control and Prevention-sponsored Laboratory Response Network (LRN) do so with the approval and support of their respective Military Department Surgeons General.

Medical Planning and Programming Lexicon

Policy
<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.